Health Care & Life Sciences » Biotechnology | China Regenerative Medicine International Ltd.

China Regenerative Medicine International Ltd.

China Regenerative Medicine International Ltd.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD1.36
Market Cap
HKD161.79 M
Shares Outstanding
17.59 B
Public Float
8.66 B

Profile

Address
Rooms 3006-10, 30/F
Hong Kong
Hong Kong
Employees -
Website http://www.crmi.hk
Updated 07/08/2019
China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development, production and sales of tissue engineering and regenerative medicine products. It operates through the following business segments: Tissue Engineering, Cell, and Cosmetic and Others, and Medical Equipment. The Tissue Engineering segment produces and sells tissue.

Financials

View All

Xuejun Wang
Chief Executive Officer & Executive Director
Ray Yip
Executive Director & Chief Medicine Officer